Aurora Cannabis Inc (ACB)
NASDAQ • Healthcare
July 27, 2026 at 20:00 UTC
About Aurora Cannabis Inc
Aurora Cannabis Inc. (NASDAQ: ACB) develops, cultivates, produces, and sells cannabis and cannabis-derived products for the healthcare market, with operations centered on medical users in Canada and abroad through wholesale and retail channels. In FY2026, the company generated CAD 321.4 million in revenue.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Aurora Cannabis Inc's Technical Indicators Summary
ACB shows a sell bias with the price below most medium and long-term moving averages even though the very short averages are near the current level, signaling longer-term downward pressure. Momentum is slightly negative, RSI is subdued, and MACD is flat, while OBV points to weak volume confirmation for any recovery. ADX is elevated, indicating a relatively strong underlying trend to the downside, and ATR is moderate as a percentage of price. Technical takeaway: Downside is confirmed by above-average trend strength and price trading under key moving averages, supporting a sell stance.
| Indicator | Value |
|---|---|
RSI (14) | 39.84 |
Stochastic %K (14, 3, 3) | 42.75 |
CCI (20) | -42.95 |
WPR (14) | -38.89 |
Momentum (10) | -0.04 |
MFI | 43.05 |
MACD Level (12, 26) | -0.10 |
Bollinger Bands | $2.54 - $2.87 |
ATR (14) | $0.10 (3.71%) |
ADX (14) | 32.50 |
OBV | 2,762,598 |
Classic Pivot Point | $2.67 |
Fibonacci Pivot Point | $2.67 |
Simple Moving Averages | $2.65 - $3.87(5 indicators) |
Exponential Moving Averages | $2.67 - $3.82(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
By the end of the session, ACB held much of its 2.62% gain versus yesterday. Into the bell, a soft sector rise of 0.53% left a constructive backdrop for ACB. ACB receives proxy-advisory support, a potential confidence boost for investors.
Trading Volume
Above 10d avg 1.2M
1.4M
vs S&P 500 Today
Outperforming Market
+2.63%
52-Week Position
Near lows
4.4%
Updated: July 27, 2026 at 21:09 UTC